Q3 2019 Holdings
Filed 2019-11-13 | 11 holdings | $176.0K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Phreesia, Inc. | Common Stock | 71948P106 | $86.6K | 3,571,213 | 49.2% |
| Cardlytics, Inc.(CDLX) | Common Stock | 14161W105 | $50.6K | 1,508,065 | 28.7% |
| Fate Therapeutics, Inc.(FATE) | Common Stock | 31189P102 | $17.7K | 1,139,783 | 10.1% |
| Neuronetics, Inc.(STIM) | Common Stock | 64131A105 | $6.1K | 732,583 | 3.5% |
| Selecta Biosciences, Inc.(SELBUSD) | Common Stock | 816212104 | $4.9K | 2,773,479 | 2.8% |
| Kala Pharmaceuticals, Inc. | Common Stock | 483119103 | $4.6K | 1,197,032 | 2.6% |
| x4 Pharmaceuticals Inc.(ASNSUSD) | Common Stock | 98420X103 | $4.0K | 311,492 | 2.2% |
| Genocea Biosciences, Inc.(GNCAQ) | Common Stock | 372427401 | $714 | 246,078 | 0.4% |
| Atyr Pharma Inc.(LIFEUSD) | Common Stock | 002120103 | $457 | 130,571 | 0.3% |
| Pulmatrix, Inc. | Common Stock | 74584P202 | $294 | 359,439 | 0.2% |
| Dare Bioscience, Inc.(CERUEUR) | Common Stock | 23666P101 | $254 | 326,243 | 0.1% |